Find a Physician | Courier | Events Calendar | About Us | Clinical Trials
 

Training Program in Signal Transduction in Cancer

Joan Lewis-Wambi and trainees

Dr. Joan Lewis-Wambi, Assistant Professor at University of Kansas and former T32 trainee, gave a recent Basic Science lecture and met with T32 trainees to give them career advice. Trainees include: Erik Ladomersky, PhD, Monal Patel, PhD, Angel Alvarez, PhD and Nikki Nwani, PhD.

Joan Lewis-Wambi and Robin Leikin

Dr. Lewis-Wambi with Robin Leikin, PhD, T32 Administrative Director.

The Postdoctoral Training Program in Signal Transduction and Cancer at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University enables four postdoctoral fellows per year to receive state-of-the-art training in signal transduction pathways and the role of aberrant signaling pathways in human cancer. Trainees receive two years of funding to conduct research to investigate the mechanism by which cytokines, growth factors and receptors control cell fate, transformation, metastasis and cell growth. This training program's preceptors are well established Northwestern University investigators with NIH funded research programs on either the Evanston or Chicago Campuses. In addition to laboratory research, the Training Program includes several formal education sessions:

Program Directors:

Program Director:
Leonidas C. Platanias, MD, PhD
Professor, Department of Medicine
Director - Lurie Cancer Center

Co-Director:
Marcus Peter, PhD
Professor, Department of Medicine

Administrative Director:
Robin Leikin, PhD
Research Assistant Professor, Lurie Cancer Center

The Training Program in Signal Transduction and Cancer is funded by the National Cancer Institute as an Institutional National Research Award (NRSA T32). In addition to the NRSA stipend, trainees receive an allocation for supplies, travel and health insurance.

Program Faculty:

Serdar Bulun, MD
Professor
Department of Obstetrics and Gynecology
Estrogen receptor action in breast cancer tissue
Debabrata Chakravarti, PhD
Associate Professor
Department of Obstetrics and Gynecology Transcriptional regulation of hormone signaling
Navdeep Chandel, PhD
Professor
Department of Medicine
Mitochondria signaling and cancer
Shi-Yuan Cheng, Ph.D
Professor
Department of Neurology
Signaling pathways in brain tumors
Elizabeth Eklund, MD
Professor of Medicine
Signaling pathways in myeloid leukemias
David Gius, MD, PhD
Professor
Department of Radiation Oncology
Molecular mechanisms of carcinogenesis
Kathleen Green, PhD
Professor
Department of Pathology
Cell adhesion molecules
Curt Horvath, PhD
Professor
Department of Molecular Biosciences
Interferon signaling pathway
C. David James, PhD
Professor
Department of Neurological Surgery
Signaling pathways of glioblastoma
Richard Longnecker, PhD
Professor
Department of Microbiology - Immunology
Signal transduction of viral infection
Daniela Matei, MD
Professor of Obstetrics and Gynecology
Ovarian cancer metastasis
Richard Morimoto, PhD
Professor
Department of Molecular Bioscience
Heat shock proteins
Hidayatullah Munshi, MD
Associate Professor
Department of Medicine Tumor cell invasion and matrix metalloproteinases
Marcus Peter, PhD
Professor
Department of Medicine Micro RNAs in cancer progression
Leonidas C. Platanias, MD, PhD
Professor
Department of Medicine
Signal transduction molecules
Ali Shilatifard, PhD
Professor
Dept. of Biochemistry and Molecular Genetics
Molecular mechanisms of leukemogenesis
Alexander Stegh, PhD
Assistant Professor of Neurology
Signaling pathways of glioblastoma and development of nanotherapy
Teresa Woodruff, PhD
Professor
Department of Obstetrics and Gynecology
Gene regulation and tumor metastasis
Jane Wu, PhD
Professor
Department of Neurology
Molecular regulation of cell migration

Junior Preceptors:

Peng Ji, PhD
Assistant Professor of Pathology
Signaling pathways in erythroid cells
Marc Mendillo, PhD
Assistant Professor of Biochemistry and Molecular Genetics Heat shock response in tumor cells
Derek Wainwright, PhD
Assistant Professor
Department of Neurological Surgery
Glioblastoma tumor induced immunosuppression

For information, contact Robin Leikin, Ph.D. Phone: (312) 908-9229